advertisement
Journal of Ocular Pharmacology and Therapeutics 5
Showing records 1 to 5 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics13259 Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits
Akaishi T; Ishida N; Shimazaki A; Hara H; Kuwayama Y
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 436-444
13272 Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study
Tsai JC; Chang HW
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 475-482
13273 Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects
Huang SF; Chen JL; Yeh MK; Chiang CH
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 445-453
13271 Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients
Sakai H; Shinjyo S; Nakamura Y; Ishikawa S; Sawaguchi S
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 483-489
13263 Dorzolamide and timolol saves retinal ganglion cells in glaucomatous adult rats
Sarup V; McEwan GC; Thompson C; Patil KA; Sharma SC
Journal of Ocular Pharmacology and Therapeutics 2005; 21: 454-462
